← Leaderboards
Veronica M Vieira
Boston University Medical Campus
$5,420,787
Attributed
$7,341,028
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $707.2K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$7,341,028 · 5
By mechanism
R01$5,597,414 · 3
P42$1,584,012 · 1
R03$159,602 · 1
Top collaborators
- Robert Edward Bristow5 shared
- Catherine Metayer3 shared
Most similar at Boston University Medical Campus
Same institution · by research overlap
- Martha M Werler$16,918,085
- Ann A Aschengrau$3,498,136
- Ann Aschengrau$2,445,311
- David H Sherr$12,083,050
- David M Ozonoff$5,975,730
Others in their field
Top investigators on “Risk Factors”
- Jeffrey P Krischer · University Of South Florida$393,499,152
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard Webby · St. Jude Children'S Research Hospital$180,330,417
- John M Lachin · George Washington University$139,236,598
Research focus
Risk FactorsBaseExposure ToLifeBirthChildCongenital AbnormalityMassachusettsStatistical ModelsCohort StudiesData SetMapsCollaborationsNovel StrategiesPatternEpidemiologyEnvironmental EpidemiologyEpidemiologic StudiesLinkProgramsCodeCohortAccountingTrend
Grant awards (22)
Exposure to per- and polyfluoroalkyl substances (PFAS) and risk of cancer in children$630,217
R01 · FY2023 · ES
Exposure to per- and polyfluoroalkyl substances (PFAS) and risk of cancer in children$635,116
R01 · FY2022 · ES
Exposure to per- and polyfluoroalkyl substances (PFAS) and risk of cancer in children$643,900
R01 · FY2021 · ES
Spatiotemporal Analysis of Disparities in Ovarian Cancer Treatment and Survival$386,250
R01 · FY2020 · MD
Spatiotemporal Analysis of Disparities in Ovarian Cancer Treatment and Survival$386,250
R01 · FY2019 · MD
Spatiotemporal Analysis of Disparities in Ovarian Cancer Treatment and Survival$386,250
R01 · FY2018 · MD
Spatiotemporal Analysis of Disparities in Ovarian Cancer Treatment and Survival$386,250
R01 · FY2017 · MD
Spatiotemporal Analysis of Disparities in Ovarian Cancer Treatment and Survival$386,250
R01 · FY2016 · MD
Project 2: Analyzing Patterns In Epidemiologic and Toxicologic Data$311,081
P42 · FY2016 · ES · contact PI
Spatial and Temporal Modeling of PM2.5 and Infant Morbidity$347,832
R01 · FY2015 · ES · contact PI
Project 2: Analyzing Patterns In Epidemiologic and Toxicologic Data$314,305
P42 · FY2015 · ES · contact PI
Spatial and Temporal Modeling of PM2.5 and Infant Morbidity$344,198
R01 · FY2014 · ES · contact PI
Project 2: Analyzing Patterns In Epidemiologic and Toxicologic Data$327,230
P42 · FY2014 · ES · contact PI
Project 2: Analyzing Patterns In Epidemiologic and Toxicologic Data$4,867
P42 · FY2014 · ES · contact PI
Project 2: Analyzing Patterns In Epidemiologic and Toxicologic Data$359,348
P42 · FY2013 · ES · contact PI
Spatial and Temporal Modeling of PM2.5 and Infant Morbidity$340,040
R01 · FY2013 · ES · contact PI
Project 2: Analyzing Patterns In Epidemiologic and Toxicologic Data$7,823
P42 · FY2013 · ES · contact PI
Spatial and Temporal Modeling of PM2.5 and Infant Morbidity$346,144
R01 · FY2012 · ES · contact PI
Project 2: Analyzing Patterns In Epidemiologic and Toxicologic Data$259,358
P42 · FY2012 · ES · contact PI
Spatial and Temporal Modeling of PM2.5 and Infant Morbidity$378,717
R01 · FY2011 · ES · contact PI
A Temporal-Spatial Analysis of Breast Cancer in Upper C*$78,852
R03 · FY2006 · CA · contact PI
A Temporal-Spatial Analysis of Breast Cancer in Upper C*$80,750
R03 · FY2005 · CA